- Home
- FBIOP vs LQDA Comparison
FBIOP vs LQDA Comparison
Compare FBIOP & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIOP
- LQDA
- Stock Information
- Founded
- FBIOP N/A
- LQDA 2004
- Country
- FBIOP United States
- LQDA United States
- Employees
- FBIOP 101
- LQDA N/A
- Industry
- FBIOP Biotechnology: Pharmaceutical Preparations
- LQDA Biotechnology: Pharmaceutical Preparations
- Sector
- FBIOP Health Care
- LQDA Health Care
- Exchange
- FBIOP Nasdaq
- LQDA Nasdaq
- Market Cap
- FBIOP N/A
- LQDA N/A
- IPO Year
- FBIOP N/A
- LQDA 2018
- Fundamental
- Price
- FBIOP $6.61
- LQDA $19.30
- Analyst Decision
- FBIOP
- LQDA Strong Buy
- Analyst Count
- FBIOP 0
- LQDA 7
- Target Price
- FBIOP N/A
- LQDA $29.00
- AVG Volume (30 Days)
- FBIOP N/A
- LQDA 1.4M
- Earning Date
- FBIOP N/A
- LQDA 05-08-2025
- Dividend Yield
- FBIOP N/A
- LQDA N/A
- EPS Growth
- FBIOP N/A
- LQDA N/A
- EPS
- FBIOP N/A
- LQDA N/A
- Revenue
- FBIOP N/A
- LQDA $14,144,000.00
- Revenue This Year
- FBIOP N/A
- LQDA $220.48
- Revenue Next Year
- FBIOP N/A
- LQDA $251.63
- P/E Ratio
- FBIOP N/A
- LQDA N/A
- Revenue Growth
- FBIOP N/A
- LQDA N/A
- 52 Week Low
- FBIOP N/A
- LQDA $8.26
- 52 Week High
- FBIOP N/A
- LQDA $16.81
- Technical
- Relative Strength Index (RSI)
- FBIOP 58.26
- LQDA 78.37
- Support Level
- FBIOP $6.15
- LQDA $14.97
- Resistance Level
- FBIOP $6.50
- LQDA $16.27
- Average True Range (ATR)
- FBIOP 0.31
- LQDA 1.04
- MACD
- FBIOP -0.02
- LQDA 0.46
- Stochastic Oscillator
- FBIOP 75.37
- LQDA 98.47
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.